Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2176219rdf:typepubmed:Citationlld:pubmed
pubmed-article:2176219lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0677626lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C1415615lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0443470lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:2176219lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:2176219pubmed:issue36lld:pubmed
pubmed-article:2176219pubmed:dateCreated1991-2-14lld:pubmed
pubmed-article:2176219pubmed:abstractTextThe level of hepatic triglyceride lipase (H-TGL) synthesis and secretion was examined in response to changes in cholesterol biosynthesis in the human hepatoma cell line HepG2. Cells were first fed a lipoprotein-deficient serum-supplemented medium to eliminate exogenous cholesterol. Mevinolin, a 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor, was then added at a concentration (37 microM) which inhibited cholesterol biosynthesis by greater than 85% and decreased total cell cholesterol from 36.1 to 27.4 micrograms/ml of cell protein. Mevinolin treatment caused a 4.9 +/- 0.8-fold increase in the amount of H-TGL activity secreted into the medium, a 1.8 +/- 0.4-fold rise in H-TGL-specific mRNA, and a concurrent 14-fold increase in HMG-CoA reductase mRNA. Addition of 1 mM mevalonic acid to normal or mevinolin-treated cells raised the cellular cholesterol content and decreased the amount of secreted H-TGL activity to levels below control values. Mevalonic acid also prevented mevinolin-induction of H-TGL and HMG-CoA reductase mRNA, suggesting a common regulatory step for H-TGL and HMG-CoA reductase. Exposure of cells to mevinolin and 25-hydroxycholesterol together resulted in a marked repression of HMG-CoA reductase mRNA levels, whereas these conditions further enhanced the secretion of H-TGL activity and the expression of H-TGL mRNA. These results demonstrate a differential role for 25-hydroxycholesterol in the regulation of H-TGL and HMG-CoA reductase expression.lld:pubmed
pubmed-article:2176219pubmed:languageenglld:pubmed
pubmed-article:2176219pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:citationSubsetIMlld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2176219pubmed:statusMEDLINElld:pubmed
pubmed-article:2176219pubmed:monthDeclld:pubmed
pubmed-article:2176219pubmed:issn0021-9258lld:pubmed
pubmed-article:2176219pubmed:authorpubmed-author:MartinG AGAlld:pubmed
pubmed-article:2176219pubmed:authorpubmed-author:JacksonR LRLlld:pubmed
pubmed-article:2176219pubmed:authorpubmed-author:FlanaganM AMAlld:pubmed
pubmed-article:2176219pubmed:authorpubmed-author:BarnhartR LRLlld:pubmed
pubmed-article:2176219pubmed:authorpubmed-author:BuschS JSJlld:pubmed
pubmed-article:2176219pubmed:issnTypePrintlld:pubmed
pubmed-article:2176219pubmed:day25lld:pubmed
pubmed-article:2176219pubmed:volume265lld:pubmed
pubmed-article:2176219pubmed:ownerNLMlld:pubmed
pubmed-article:2176219pubmed:authorsCompleteYlld:pubmed
pubmed-article:2176219pubmed:pagination22474-9lld:pubmed
pubmed-article:2176219pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:meshHeadingpubmed-meshheading:2176219-...lld:pubmed
pubmed-article:2176219pubmed:year1990lld:pubmed
pubmed-article:2176219pubmed:articleTitleDifferential regulation of hepatic triglyceride lipase and 3-hydroxy-3-methylglutaryl-CoA reductase gene expression in a human hepatoma cell line, HepG2.lld:pubmed
pubmed-article:2176219pubmed:affiliationMerrell Dow Research Institute, Cincinnati, Ohio 45215.lld:pubmed
pubmed-article:2176219pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2176219pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176219lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2176219lld:pubmed